Novartis is a global healthcare company based in Basel, Switzerland, with a history going back more than 150 years. We provide healthcare solutions that address the evolving needs of patients and societies worldwide.
Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
Novartis has been serving Indonesian patients for more than 50 years, through our predecessor companies, Ciba and Sandoz. Under one legal entity of PT Novartis Indonesia, we continue to provide our innovative medicines to Indonesian patients and demonstrate our commitment in improving healthcare system in Indonesia through public private partnerships.
Novartis Indonesia Head Office is located in AXA Tower, Kuningan, Jakarta, while our factory/site is located in Pasar Rebo, Jakarta.
Our Focus Therapeutic Areas
Cardio Metabolic
We are passionate about research, development and quality manufacturing of novel therapies and solutions to reduce the burden of diseases in communities around the world. We focus our efforts on diseases that negatively affect the heart, kidney, liver and blood vessels with the goal of better patient outcomes.
Oncology: Hematology and Solid Tumor
Our Oncology is a leader in driving the practice of precision oncology treatment. Precision oncology is the evolving understanding of how cancers develop on a genomic level and our ability to develop drugs that hone in on those targets – ultimately leading to better patient outcomes. Our research, driven by a distinctive scientific and clinical strategy, focuses on unmet medical needs and disease pathways.
Dermatology and Immunology
Our Immunology and Dermatology is transforming patients’ lives by preventing progressive illnesses and successfully treating co-morbidities in the Specialty Dermatology, Rheumatology and Transplantation fields, where there are remaining high unmet medical needs.
